Abstract
In this issue of Cancer Biotherapy and Radiopharmaceuticals, we are going to try what is a bit of an experiment. We are going to try grouping content together thematically for a few issues, perhaps somewhat loosely as needed, based on disease categories. As you might have noticed in the current table of contents, this issue contains what might be broadly described as research articles that directly pertain to women's malignancies, for example, breast cancer, cervical cancer, ovarian cancer, and related topics. We are trying this to test whether this organization and presentation of research appeal to both readers and authors of Cancer Biotherapy and Radiopharmaceuticals. Given the accepted available content for publication, we will test the hypothesis that this mode of presentation is of interest. I look forward to hearing any and all feedback (